Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches

Part of paid clinical trials in San Diego, California.

Sponsor
Veterans Medical Research Foundation
Study ID
NCT05176392
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Active rTMS — DEVICE
    Active rTMS will be given at the left dorsolateral prefrontal cortex with a double blind TMS coil.
  • Headache Management Therapy — BEHAVIORAL
    Therapy will be provided on headache management.
  • Sham rTMS — DEVICE
    Sham rTMS will be given at the left dorsolateral prefrontal cortex. All parameters of the treatment will appear identical to the active treatment, with only the rTMS coil used to administer the treatment flipped 180 degrees to prevent stimulation.
  • Headache Education Control — BEHAVIORAL
    In the control, educational sessions on headaches will be provided.

Study Details

This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild traumatic brain injury (mTBI) related headaches. The investigators hypothesize that active rTMS combined with telehealth therapy will provide marked reduction in mTBI related headaches and symptoms in comparison to their placebo counterparts.

Key Dates

Start date
Jan 1, 2022
Status verified
Nov 2024
Primary completion
Aug 31, 2025
Completion
Aug 31, 2025

Study Design

Enrollment
240 participants (estimated)
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Active rTMS with telehealth headache management therapy
    Participants receive both active rTMS treatment at the left dorsolateral prefrontal cortex and therapy for headache management
  • Other: Active rTMS with telehealth headache education control
    Participants receive active rTMS treatment at the left dorsolateral prefrontal cortex and headache education
  • Other: Sham rTMS with telehealth headache management therapy
    Participants receive sham rTMS treatment at the left dorsolateral prefrontal cortex and therapy for headache management
  • Sham Comparator: Sham rTMS with telehealth headache education control
    Participants receive sham rTMS treatment at the left dorsolateral prefrontal cortex and headache education

Primary Outcome Measure

Intensity of Persistent Headaches [ Time Frame: Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
VA San Diego Healthcare SystemSan DiegoCalifornia92161
Caleb Lopez, BS
858-552-8585
Albert Y Leung, MD

Find similar trials in San Diego, CA

By condition

Related Studies